OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serum CCL22 levels decreased in parallel with disease activity in CCR4 ‐positive mycosis fungoides treated with mogamulizumab
Kentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 8
Kentaro Ohuchi, Taku Fujimura, Chunbing Lyu, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 8
Showing 8 citing articles:
CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD‐L1 via activation of STAT3 pathway
Shutao Zheng, Tongxue Shen, Qing Liu, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5373-5386
Closed Access | Times Cited: 34
Shutao Zheng, Tongxue Shen, Qing Liu, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5373-5386
Closed Access | Times Cited: 34
Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma
Zhen Han, Xiwei Wu, Hanjun Qin, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 10
Zhen Han, Xiwei Wu, Hanjun Qin, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 10
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment
Liangliang Meng, Xiaoxi He, Quan Hong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Liangliang Meng, Xiaoxi He, Quan Hong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
Potential role of tumor‐associated macrophages and CD163 /CD68 ratio in mycosis fungoides and Sézary syndrome in correlation with serum sCD163 and CCL22
Dina M. El‐Guindy, Lamia Hamouda Elgarhy, Rasha A. Elkholy, et al.
Journal of Cutaneous Pathology (2021) Vol. 49, Iss. 3, pp. 261-273
Closed Access | Times Cited: 7
Dina M. El‐Guindy, Lamia Hamouda Elgarhy, Rasha A. Elkholy, et al.
Journal of Cutaneous Pathology (2021) Vol. 49, Iss. 3, pp. 261-273
Closed Access | Times Cited: 7
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications
Daniel E. Luna, Michi M. Shinohara
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 3, pp. 83-88
Closed Access | Times Cited: 2
Daniel E. Luna, Michi M. Shinohara
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 3, pp. 83-88
Closed Access | Times Cited: 2
